Skip to content

NEURO-PATCH 1064029Recalls & reported problems

Aesculap AG · NEURO-PATCH 6X8CM · Class 2 · Implant

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 04038653700783), received between Feb 10, 2022 and Feb 10, 2022 — classified as 1 injury.

The most frequently reported specific device problem is “Gel Leak” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Gel Leak1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryFeb 10, 2022Gel Leak; Gel Leak

    IT WAS REPORTED TO AESCULAP AG THAT A NEURO-PATCH 6X8CM (PART # 1064029) WAS USED DURING A DETETHERING THE SPINAL CORD AND REPAIR DURA DEFECT PROCEDURE PERFORMED ON (B)(6) 2021. ACCORDING TO THE COMPLAINANT, LEAKAGE OCCURRED AFTER SUTURE. THE PATCH WAS NOT REPLACED, HOWEVER, THE PHYSICIAN USED DURAGEN AND TISSUE GEL TO PREVENT FURTHER LEAKAGE. REPORTEDLY, THE WOUND HAS NO EXUDATION AT PRESENT, THE PATIENT IS RECOVERING WELL. AN ADDITIONAL MEDICAL INTERVENTION WAS NECESSARY. THE ADVERSE EVENT IS FILED UNDER AAG REFERENCE (B)(4).

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 13509336 ↗

Other DURA SUBSTITUTE devices

All DURA SUBSTITUTE devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page